TipRanks
Go Ultimate55% OFF

Alterity Therapeutics (ATHE) Q2 2026 Earnings Report

ATHE Q2 2026 EPS Results

Actual EPS
-$0.38
Consensus EPS
-$0.23
Beat/Miss
Missed by -$0.15
One Year Ago EPS
-$0.52

ATHE Q2 2026 Revenue Results

Actual Revenue
$0
Expected Revenue
$1.07M
Beat/Miss
Missed by -$1.07M
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q2 2026
Date
02/25/2026
Time
After Close
Conference Call
Wednesday, February 25, 2026
ATHE Upcoming Earnings

Alterity Therapeutics's next earnings date is estimated for March 4, 2027, based on past reporting schedules.

Q2 2026 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2026 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2026 Earnings Call Summary

No earnings call summary is available for this earnings event.

ATHE Earnings History

ATHE earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 04, 20272027 (Q2)-0.03--0.38――
Feb 25, 20262026 (Q2)-0.23-0.38-0.5226.63% (+0.14)
Feb 28, 20252025 (Q2)-0.64-0.52-0.6215.53% (+0.10)
Feb 28, 20242024 (Q2)-0.13-0.62-1.3353.71% (+0.72)
Feb 28, 20232023 (Q2)-2.17-1.33-1.18-13.52% (-0.16)
Feb 28, 20222022 (Q2)―-1.18-2.8458.55% (+1.66)
Feb 25, 20212021 (Q2)―-2.84-2.67-6.29% (-0.17)
Feb 27, 20202020 (Q2)―-2.673.52-175.78% (-6.19)
Feb 28, 20192019 (Q2)―3.52-2.18261.26% (+5.71)
Aug 31, 20182018 (Q4)―-0.40-0.33-21.82% (-0.07)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed
Show More